If your proposed project is exempt from ongoing IRBMED oversight but you or any member of your study team will be accessing Protected Health Information (PHI), the project must be reviewed by the Privacy Board. You will need to complete an exempt application through eResearch, including Sections 25-1 and 25-2.
For more information, see Exempt human subjects research guidance. Most commonly exempt research with PHI is either
Exemption 2 using PHI only to identify eligible subjects
Exemption 4 viewing but not recording PHI as part of a secondary use analysis of clinical data.